Patent application number | Description | Published |
20090041666 | Ophthalmic formulations of Amyloid-beta contrast agent and methods of use thereof - The invention provides ophthalmic formulations of Amyloid-β contrast agents. Also provided are methods of using such formulations in the diagnosis of Alzheimer's Disease or a predisposition thereto as well as methods for the prognosis of Alzheimer's Disease. | 02-12-2009 |
20100122918 | OPHTHALMIC AND CONTACT LENS SOLUTION - An ophthalmic solution comprising a polyethoxylated glyceride in the range of 0.001 to about 10 percent by weight and a buffer agent. These solutions impart surprising comfort and wearability to contact lenses. At the same time the solutions provide good preservative capacity and do not increase protein deposit. | 05-20-2010 |
20110212885 | OPHTHALMIC AND CONTACT LENS SOLUTIONS CONTAINING PEPTIDES AS PRESERVATIVE - A method and a contact lens solution comprising 0.001 to 10 weight percent or a preservative enhancer chosen from the group consisting of: SEQ ID NO.1 and SEQ ID NO. 2; and at least 0.0001 weight percent of a preservative agent, and where the concentration of chloride in said solution is less than 0.2 percent by weight. | 09-01-2011 |
20120017806 | Ophthalmic and Contact Lens Solutions Using Low Molecular Weight Amines - The present invention relates to a lens care solution comprising:
| 01-26-2012 |
20120083534 | OPHTHALMIC AND CONTACT LENS SOLUTION - An ophthalmic solution comprising a polyethoxylated glyceride in the range of 0.001 to about 10 percent by weight and a buffer agent. These solutions impart surprising comfort and wearability to contact lenses. At the same time the solutions provide good preservative capacity and do not increase protein deposit. | 04-05-2012 |
20130079422 | OPHTHALMIC CONTACT LENS SOLUTIONS CONTAINING FORMS OF VITAMIN B - The present invention relates to improved ophthalmic solutions that employ select B vitamins; pyridoxine and its salts; and thiamine and its salts in order to more effectively preserve solutions and to reduce the degree to which cationic preservatives will deposit on contact lenses. Ophthalmic solutions are here understood to include contact lens treatment solutions, such as cleaners, soaking solutions, conditioning solutions and lens storage solutions, as well as wetting solutions and in-eye solutions for treatment of eye conditions. | 03-28-2013 |
20130228477 | OPHTHALMIC AND CONTACT LENS SOLUTIONS USING TRICINE - The present invention relates to a lens care solution having 0.001 to about 5 weight percent of a low molecular weight amine of the general formula: | 09-05-2013 |
20130233201 | OPHTHALMIC AND CONTACT LENS SOLUTIONS USING AN ALIPHATIC AMINO ALCOHOL - The present invention relates to a lens care solution having 0.001 to about 5 weight percent of a low molecular weight amine of the general formula: | 09-12-2013 |
20130233734 | OPHTHALMIC AND CONTACT LENS SOLUTIONS USING CARNITINE - The present invention relates to a lens care solution having 0.001 to about 5 weight percent of a low molecular weight amine of the general formula: | 09-12-2013 |
20130233740 | OPHTHALMIC AND CONTACT LENS SOLUTIONS USING BIS-TRIS - The present invention relates to a lens care solution having 0.001 to about 5 weight percent of a low molecular weight amine of the general formula: | 09-12-2013 |
20130237606 | OPHTHALMIC AND CONTACT LENS SOLUTIONS USING CHOLINE - The present invention relates to a lens care solution having 0.001 to about 5 weight percent of a low molecular weight amine of the general formula: | 09-12-2013 |
20140093472 | L-HISTIDINE IN OPHTHALMIC SOLUTIONS - The invention relates to an aqueous ophthalmic solution comprising 0.00001 to about 10.0 percent by weight L-histidine, 0.0001 to 3.0 percent by weight hydrogen peroxide, and optionally 0.1 to 500 parts per million of a preservative that provides superior preservative efficacy especially as against fungal microbes. These solutions may be employed in various ways including cleaning contact lenses, rinsing lenses while in the eye, storing lenses and in delivering active pharmaceutical agents to the eye. | 04-03-2014 |
20140163113 | OPHTHALMIC AND CONTACT LENS SOLUTIONS USING CHOLINE - The present invention relates to a lens care solution having 0.001 to about 5 weight percent of a low molecular weight amine of the general formula: | 06-12-2014 |